General Information of Drug (ID: DMYMA8G)

Drug Name
JNJ-63682931
Indication
Disease Entry ICD 11 Status REF
Human papillomavirus infection 1A9Y Phase 1/2 [1]
Drug Type
Vaccine
Cross-matching ID
TTD ID
D8RN3B

References

1 ClinicalTrials.gov (NCT03610581) Safety, Reactogenicity and Immunogenicity of Adenovirus Serotype 26 (Ad26)- and Modified Vaccinia Ankara (MVA)-Vectored Vaccine Components in Otherwise Healthy Women With HPV16 or HPV18 Infection of the Cervix. U.S. National Institutes of Health.